Blueprint Medicines Corp (BPMC) Company Profile & Statistics

Blueprint Medicines Corp
BPMC
(Nasdaq - US)
Open
88.83
+0.14 (+0.16%)
in:usd•As of: Nov 18, 2024 12:23 UTC -5
Open
89.02
High
90.65
Low
88.07

About Blueprint Medicines Corp

CEO

Kathryn Haviland

Headquarters

45 sidney street

cambridge, ma 02139, united states

Auditor

Ernst & Young LLP

Employees

655

Share Holders

Website

www.blueprintmedicines.com

Industry

biotechnology

Sector

health technology

Company Overview

Blueprint Medicines Corporation is a biopharmaceutical company focused on developing the potentially transformational precision medicines to address patients with genomically defined cancers and rare diseases.

Blueprint Medicines Corp Statistics

Valuation Measures

Market Capitalization ²	5.64B
Enterprise Value	5.95B
Enterprise Value/EBITDA (ttm)	-20.87
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	17.99
Price to Sales (ttm)	12.97
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	97.34%
Operating Margin (ttm)	-69.45%
Profit Margin (ttm)	-35.37%
Return on Equity (ttm)	-112.30%
Return on Invested Capital (ttm)	-31.74%
Return on Assets (ttm)	-26.87%

Income Statement

Revenue (ttm)	434.41M
Revenue Per Share (ttm)	6.84
Gross Profit (ttm)	421.48M
EBITDA (ttm)³	-285.24M
Net Income Avi to Common (ttm)	-128.05M
Diluted EPS (ttm)	-2.11

Share Statistics

Beta (5Y Monthly)	0.59
52-Week Change	34.84%
S&P500 52-Week Change	29.63%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	63.53M
Dividend Yield	0.00%
Float ⁴	60.85M
% Held by Insiders	4.21%
% Held by Institutions	N/A

Balance Sheet

Total Cash (mrq)	734.17M
Total Cash Per Share (mrq)	11.56
Total Debt (mrq)	399.58M
Total Debt/Equity (mrq)	127.60%
Current Ratio (mrq)	3.32%
Quick Ratio (mrq)	3.27%
Book Value Per Share (mrq)	4.93

Cash Flow

Operating Cash Flow Per Share (ytd)	-2.58
Free Cash Flow (ytd)	-166.92M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Blueprint Medicines Corp

Trade With A Regulated Broker